Zhuo Lin

Zhuo Lin

Auto-generated profile, based on publicly available information

Zhuo Lin

Department of Liver Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, Zhejiang Province, P.R. China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2016 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
RCR.‐C. Chen
R.‐C. Chen
YCY.‐J. Cai
Y.‐J. Cai
JWJ.‐M. Wu
J.‐M. Wu
XWX.‐D. Wang
X.‐D. Wang
MSM. Song
M. Song
KSkeqing shi
keqing shi

1 September 2021 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
WZWeiwei Zhuang
Weiwei Zhuang
HSHongwei Sun
Hongwei Sun
SZShanshan Zhang
Shanshan Zhang
YZYilin Zhou
Yilin Zhou
WWWanqing Weng
Wanqing Weng
KSkeqing shi
keqing shi
Immunity plays an important role in tumor development. In this study, we aimed to investigate molecular classification and its prognostic value in hepatocellular carcinoma (HCC) based on immune signature. Gene set enrichment analysis (GSEA) was used to calculate scores of immune pathways for HCC and hierarchical clustering in two databases (The Cancer Genome Atlas [TCGA], Liver Cancer-RIKEN, JP [LIRI_JP]). The scores of the immune microenvironment and the proportions of 22 immune cells were also calculated. Single-sample GSEA (ssGSEA) was used to screen survival prognosis-related immune pathways and calculate the hazard radio of differentially expressed immune-related genes (IRGs), which were validated in clinical samples and multiple datasets. Based on the immune characteristics, we identified three HCC subtypes, namely immunity high (Immunity_H), immunity medium (Immunity_M), and immunity low (Immunity_L), and confirmed that the classification was reliable and predictable. Immunity_H with a higher immune and stromal score indicated better survival rate. Cox regression analysis showed that IL18RAP and IL7R were the protective genes. Immune risk score was the independent risk factor of overall survival in HCC patients. These results indicated that immunogenomic classification could distinguish HCC patients with different immune status, which could impact the prognosis of the patients with HCC.

10 October 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
XCXiangJian Chen
XiangJian Chen
KSKeQing Shi
KeQing Shi
YWYuQun Wang
YuQun Wang
MSMei Song
Mei Song
WZWu Zhou
Wu Zhou
ZLZhuo Lin
Zhuo Lin
Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation

1 December 2019
Verified
Journal Article
Open access
FLFeng-Bin Lu
Feng-Bin Lu
DCDazhi Chen
Dazhi Chen
LCLu Chen
Lu Chen
EHEn-De Hu
En-De Hu
JWJin-Lu Wu
Jin-Lu Wu
Yongping ChenYongping Chen
Yongping Chen
MicroRNA- 223-3p (miR-223-3p) is one of the potential microRNAs that have been shown to alleviate inflammatory responses in pre-clinical investigations and is highly encased in exosomes derived from bone mesenchymal stem cells (MSC-exosomes). MSC-exosomes are able to function as carriers to deliver microRNAs into cells. Autoimmune hepatitis is one of the challenging liver diseases with no effective treatment other than steroid hormones. Here, we examined whether MSC-exosomes can transfer miR-223-3p to treat autoimmune hepatitis in an experimental model. We found that MSC-exosomes were successfully incorporated with miR-223-3p and delivered miR-223-3p into macrophages. Moreover, there was no toxic effect of exosomes on the macrophages. Furthermore, treatments of either exosomes or exosomes with miR-223-3p successfully attenuated inflammatory responses in the liver of autoimmune hepatitis and inflammatory cytokine release in both the liver and macrophages. The mechanism may be related to the regulation of miR-223-3p level and STAT3 expression in the liver and macrophages. These results suggest that MSC-exosomes can be used to deliver miR-223-3p for the treatment of autoimmune hepatitis.

1 June 2017 in Clinica Chimica Acta
Verified
Journal Article
Closed access
YCYi-Jing Cai
Yi-Jing Cai
JDJia-Jia Dong
Jia-Jia Dong
JDJin-Zhong Dong
Jin-Zhong Dong
NYNai-Bing Yang
Nai-Bing Yang
MSMei Song
Mei Song
KSkeqing shi
keqing shi

24 December 2020 in Epigenomics
Verified
Journal Article
Closed access
WHWeiguo Huang
Weiguo Huang
WWWanqing Weng
Wanqing Weng
BWBoda Wu
Boda Wu
TYTingbo Ye
Tingbo Ye
ZLZhuo Lin
Zhuo Lin
KSkeqing shi
keqing shi
Aim: To develop a trans-omics-based molecular clinicopathological algorithm for predicting pancreatic adenocarcinoma prognosis, we performed a comprehensive analysis of the expression levels of mRN...